9
Participants
Start Date
April 30, 2004
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
autologous tumor cell vaccine
therapeutic autologous dendritic cells
tumor cell-derivative vaccine therapy
Cancer Research Center at Boston Medical Center, Boston
Lead Sponsor
Boston Medical Center
OTHER